Reclassified historical segment results are unaudited estimates.
Due to rounding, numbers presented may not add up precisely to the totals indicated.


Segmentation Basis (prior to 2Q22)
Earnings/(Loss), $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Upstream
United States (18) (183) (238) 7,061 6,622 429 439 606 265 1,739 96 335 37 68 536 (704) (1,197) (681) (16,803) (19,385) 363 663 869 1,768 3,663 2,376
Non-U.S. 2,270 1,367 1,805 1,291 6,733 3,068 2,601 3,623 3,048 12,340 2,780 2,926 2,131 6,069 13,906 1,240 (454) 298 (1,729) (645) 2,191 2,522 3,082 4,317 12,112 2,112
Total 2,252 1,184 1,567 8,352 13,355 3,497 3,040 4,229 3,313 14,079 2,876 3,261 2,168 6,137 14,442 536 (1,651) (383) (18,532) (20,030) 2,554 3,185 3,951 6,085 15,775 4,488
Downstream
United States 292 347 391 918 1,948 319 695 961 987 2,962 (161) 310 673 895 1,717 (101) (101) (136) (514) (852) (113) (149) 663 913 1,314 685
Non-U.S. 824 1,038 1,141 646 3,649 621 29 681 1,717 3,048 (95) 141 557 3 606 (510) 1,077 (95) (697) (225) (277) (78) 592 554 791 (353)
Total 1,116 1,385 1,532 1,564 5,597 940 724 1,642 2,704 6,010 (256) 451 1,230 898 2,323 (611) 976 (231) (1,211) (1,077) (390) (227) 1,255 1,467 2,105 332
Chemical
United States 529 481 403 777 2,190 503 453 404 282 1,642 161 (6) 53 (2) 206 288 171 357 461 1,277 715 1,282 1,183 1,322 4,502 819
Non-U.S. 642 504 689 493 2,328 508 437 309 455 1,709 357 194 188 (353) 386 (144) 296 304 230 686 700 1,038 957 599 3,294 535
Total 1,171 985 1,092 1,270 4,518 1,011 890 713 737 3,351 518 188 241 (355) 592 144 467 661 691 1,963 1,415 2,320 2,140 1,921 7,796 1,354
Corporate and Financing (529) (204) (221) (2,806) (3,760) (798) (704) (344) (754) (2,600) (788) (770) (469) (990) (3,017) (679) (872) (727) (1,018) (3,296) (849) (588) (596) (603) (2,636) (694)
Net Income/(Loss) attributable
to ExxonMobil (U.S. GAAP)
4,010 3,350 3,970 8,380 19,710 4,650 3,950 6,240 6,000 20,840 2,350 3,130 3,170 5,690 14,340 (610) (1,080) (680) (20,070) (22,440) 2,730 4,690 6,750 8,870 23,040 5,480
Segmentation Basis (effective 2Q22)
Earnings/(Loss), $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Upstream
United States (18) (183) (238) 7,061 6,622 429 439 606 265 1,739 96 335 37 68 536 (704) (1,197) (681) (16,803) (19,385) 363 663 869 1,768 3,663 2,376
Non-U.S. 2,270 1,367 1,805 1,291 6,733 3,068 2,601 3,623 3,048 12,340 2,780 2,926 2,131 6,069 13,906 1,240 (454) 298 (1,729) (645) 2,191 2,522 3,082 4,317 12,112 2,112
Total 2,252 1,184 1,567 8,352 13,355 3,497 3,040 4,229 3,313 14,079 2,876 3,261 2,168 6,137 14,442 536 (1,651) (383) (18,532) (20,030) 2,554 3,185 3,951 6,085 15,775 4,488
Energy Products
United States 255 263 319 856 1,693 279 631 953 1,059 2,922 (195) 203 589 828 1,425 (183) (212) (300) (648) (1,342) (232) (278) 479 699 668 489
Non-U.S. 594 655 804 425 2,477 400 (172) 559 1,561 2,348 (175) 21 335 (164) 17 (645) 895 (399) (1,081) (1,230) (689) (578) 50 203 (1,014) (684)
Total 849 918 1,122 1,280 4,170 679 459 1,512 2,620 5,270 (369) 223 924 664 1,442 (828) 683 (699) (1,728) (2,572) (921) (856) 529 901 (347) (196)
Chemical Products
United States 426 389 342 598 1,754 441 382 313 203 1,339 103 (23) 2 14 97 220 174 364 439 1,196 654 1,149 1,121 774 3,697 770
Non-U.S. 571 482 663 509 2,225 492 483 293 388 1,655 332 289 298 (240) 679 (4) 278 360 427 1,061 737 1,051 907 597 3,292 636
Total 997 870 1,005 1,107 3,979 933 865 606 591 2,994 435 266 301 (226) 776 215 451 724 866 2,257 1,391 2,200 2,027 1,371 6,989 1,405
Specialty Products
United States 140 176 133 241 691 101 135 99 8 343 92 124 134 51 401 151 108 156 156 571 180 262 247 763 1,452 246
Non-U.S. 301 406 364 205 1,276 238 155 138 223 754 105 26 112 54 296 (5) 200 248 187 630 375 487 592 353 1,807 230
Total 441 582 497 446 1,966 339 290 237 231 1,097 196 150 246 105 697 146 309 405 342 1,201 555 750 839 1,116 3,259 476
Corporate and Financing (529) (204) (221) (2,806) (3,760) (798) (704) (344) (754) (2,600) (788) (770) (469) (990) (3,017) (679) (872) (727) (1,018) (3,296) (849) (588) (596) (603) (2,636) (694)
Net Income/(Loss) attributable
to ExxonMobil (U.S. GAAP)
4,010 3,350 3,970 8,380 19,710 4,650 3,950 6,240 6,000 20,840 2,350 3,130 3,170 5,690 14,340 (610) (1,080) (680) (20,070) (22,440) 2,730 4,690 6,750 8,870 23,040 5,480


Attachment II - Identified Items Recast
Reclassified historical segment results are unaudited estimates.
Due to rounding, numbers presented may not add up precisely to the totals indicated.
As per previously reported data. Identified items as per frequently used terms from 2018 onwards. 2017 data shows reported Asset Impairments and U.S. Tax reform impacts.

Earnings/(loss) excluding identified items are earnings/(loss) excluding individually significant non-operational events with an absolute corporate total earnings impact of at least $250 million in a given quarter. The earnings/(loss) impact of an identified item for an individual segment may be less than $250 million when the item impacts several periods or several segments. Earnings/(loss) excluding identified items does include non-operational earnings events or impacts that are below the $250 million threshold utilized for identified items. When the effect of these events are material in aggregate, they are indicated in analysis of period results as part of quarterly earnings press release and teleconference materials. Management uses these figures to improve comparability of the underlying business across multiple periods by isolating and removing significant non-operational events from business results. The Corporation believes this view provides investors increased transparency into business results and trends, and provides investors with a view of the business as seen through the eyes of management. Earnings excluding identified items is not meant to be viewed in isolation or as a substitute for net income/(loss) attributable to ExxonMobil as prepared in accordance with U.S. GAAP.


Segmentation Basis (prior to 2Q22)
Identified Items Earnings/(Loss), $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Upstream
United States Impairments - - (40) (481) (521) - - - - - - - - - - (315) - - (16,777) (17,092) - - - (263) (263) -
Gain/(loss) on sale of assets - - - - - - - - - - - - - - - - - - - - - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (45) 45 - - - - - - - - -
Tax-related items - - - 7,602 7,602 - - - - - - - - - - - - - - - - - - - - -
Other - - - - - - - - (274) (274) - - - - - - - - - - - - - - - -
Total - - (40) 7,121 7,081 - - - (274) (274) - - - - - (360) 45 - (16,777) (17,092) - - - (263) (263) -
Non-U.S. Impairments - (118) (58) (807) (983) - - - - - - - - - - (41) - - (2,203) (2,244) - - - (489) (489) (2,877)
Gain/(loss) on sale of assets - - - - - 366 - - - 366 - - - 3,679 3,679 - - - - - - - - 459 459 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (218) 168 (11) - (61) - - - - - -
Tax-related items - - - (480) (480) - - 271 - 271 - 487 - 268 755 - - - (297) (297) - - - - - -
Other - - - - - - - - (96) (96) - - - - - - - - - - - - - (250) (250) (378)
Total - (118) (58) (1,287) (1,463) 366 - 271 (96) 541 - 487 - 3,947 4,434 (259) 168 (11) (2,500) (2,602) - - - (280) (280) (3,255)
Total Impairments - (118) (98) (1,288) (1,504) - - - - - - - - - - (356) - - (18,980) (19,336) - - - (752) (752) (2,877)
Gain/(loss) on sale of assets - - - - - 366 - - - 366 - - - 3,679 3,679 - - - - - - - - 459 459 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (263) 213 (11) - (61) - - - - - -
Tax-related items - - - 7,122 7,122 - - 271 - 271 - 487 - 268 755 - - - (297) (297) - - - - - -
Other - - - - - - - - (370) (370) - - - - - - - - - - - - - (250) (250) (378)
Total - (118) (98) 5,834 5,618 366 - 271 (370) 267 - 487 - 3,947 4,434 (619) 213 (11) (19,277) (19,694) - - - (543) (543) (3,255)
Downstream
United States Impairments - - - (6) (6) - - - - - - - - - - (4) - - - (4) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - - - - - - - - - - - - - - - - 4 4 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (407) 404 3 - - - - - - - -
Tax-related items - - - 618 618 - - - - - - - - - - - - - - - - - - - - -
Total - - - 612 612 - - - - - - - - - - (411) 404 3 - (4) - - - 4 4 -
Non-U.S. Impairments - - (11) - (11) - - - - - - - - - - (335) - - (258) (593) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 888 888 - - - - - - - - - - - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (1,196) 1,190 6 - - - - - - - -
Tax-related items - - - - - - - - 57 57 - (9) - - (9) - - - (262) (262) - - - - - -
Total - - (11) - (11) - - - 945 945 - (9) - - (9) (1,531) 1,190 6 (520) (855) - - - - - -
Total Impairments - - (11) (6) (17) - - - - - - - - - - (339) - - (258) (597) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 888 888 - - - - - - - - - - - - - 4 4 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (1,603) 1,594 9 - - - - - - - -
Tax-related items - - - 618 618 - - - 57 57 - (9) - - (9) - - - (262) (262) - - - - - -
Total - - (11) 612 601 - - - 945 945 - (9) - - (9) (1,942) 1,594 9 (520) (859) - - - 4 4 -


Segmentation Basis (prior to 2Q22)- Continued
Identified Items Earnings/(Loss), $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Chemical
United States Impairments - - - - - - - - - - - - - - - (90) - - - (90) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - - - - - - - - - - - - - - - - 494 494 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - - (29) 29 - - - - - - - -
Tax-related items - - - 335 335 - - - - - - - - - - - - - - - - - - - - -
Total - - - 335 335 - - - - - - - - - - (90) (29) 29 - (90) - - - 494 494 -
Non-U.S. Impairments - - - - - - - - - - - - - - - (2) - - - (2) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - - - - - - - - - - - - - - - - 136 136 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (230) 144 86 - - - - - - - -
Tax-related items - - - - - - - - 212 212 - 2 - - 2 - - - (22) (22) - - - - - -
Total - - - - - - - - 212 212 - 2 - - 2 (232) 144 86 (22) (24) - - - 136 136 -
Total Impairments - - - - - - - - - - - - - - - (92) - - - (92) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - - - - - - - - - - - - - - - - 630 630 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (230) 115 115 - - - - - - - -
Tax-related items - - - 335 335 - - - 212 212 - 2 - - 2 - - - (22) (22) - - - - - -
Total - - - 335 335 - - - 212 212 - 2 - - 2 (322) 115 115 (22) (114) - - - 630 630 -
Corporate and Financing Impairments - - - - - - - - - - - - - - - - - - (35) (35) - - - - - (98)
Gain/(loss) on sale of assets - - - - - - - - (6) (6) - - - (24) (24) - - - - - - - - (12) (12) -
Severance - - - - - - - - - - - - - - - - - - (326) (326) (31) (12) (5) (4) (52) -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax-related items - - - (2,133) (2,133) - - 348 - 348 - 25 307 - 332 - - - - - - - - - - -
Total - - - (2,133) (2,133) - - 348 (6) 342 - 25 307 (24) 308 - - - (361) (361) (31) (12) (5) (16) (64) (98)
Identified items impact attributable to ExxonMobil Impairments - (118) (109) (1,294) (1,521) - - - - - - - - - - (787) - - (19,273) (20,060) - - - (752) (752) (2,975)
Gain/(loss) on sale of assets - - - - - 366 - - 882 1,248 - - - 3,655 3,655 - - - - - - - - 1,081 1,081 -
Severance - - - - - - - - - - - - - - - - - - (326) (326) (31) (12) (5) (4) (52) -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (2,096) 1,922 113 - (61) - - - - - -
Tax-related items - - - 5,942 5,942 - - 619 269 888 - 505 307 268 1,080 - - - (581) (581) - - - - - -
Other - - - - - - - - (370) (370) - - - - - - - - - - - - - (250) (250) (378)
Total - (118) (109) 4,648 4,421 366 - 619 781 1,766 - 505 307 3,923 4,735 (2,883) 1,922 113 (20,180) (21,028) (31) (12) (5) 75 27 (3,353)


Segmentation Basis (effective 2Q22)
Identified Items Earnings/(Loss), $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Upstream
United States Impairments - - (40) (481) (521) - - - - - - - - - - (315) - - (16,777) (17,092) - - - (263) (263) -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (45) 45 - - - - - - - - -
Tax-related items - - - 7,602 7,602 - - - - - - - - - - - - - - - - - - - - -
Other - - - - - - - - (274) (274) - - - - - - - - - - - - - - - -
Total - - (40) 7,121 7,081 - - - (274) (274) - - - - - (360) 45 - (16,777) (17,092) - - - (263) (263) -
Non-U.S. Impairments - (118) (58) (807) (983) - - - - - - - - - - (41) - - (2,203) (2,244) - - - (489) (489) (2,877)
Gain/(loss) on sale of assets - - - - - 366 - - - 366 - - - 3,679 3,679 - - - - - - - - 459 459 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (218) 168 (11) - (61) - - - - - -
Tax-related items - - - (480) (480) - - 271 - 271 - 487 - 268 755 - - - (297) (297) - - - - - -
Other - - - - - - - - (96) (96) - - - - - - - - - - - - - (250) (250) (378)
Total - (118) (58) (1,287) (1,463) 366 - 271 (96) 541 - 487 - 3,947 4,434 (259) 168 (11) (2,500) (2,602) - - - (280) (280) (3,255)
Total Impairments - (118) (98) (1,288) (1,504) - - - - - - - - - - (356) - - (18,980) (19,336) - - - (752) (752) (2,877)
Gain/(loss) on sale of assets - - - - - 366 - - - 366 - - - 3,679 3,679 - - - - - - - - 459 459 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (263) 213 (11) - (61) - - - - - -
Tax-related items - - - 7,122 7,122 - - 271 - 271 - 487 - 268 755 - - - (297) (297) - - - - - -
Other - - - - - - - - (370) (370) - - - - - - - - - - - - - (250) (250) (378)
Total - (118) (98) 5,834 5,618 366 - 271 (370) 267 - 487 - 3,947 4,434 (619) 213 (11) (19,277) (19,694) - - - (543) (543) (3,255)
Energy Products
United States Impairments - - - (6) (6) - - - - - - - - - - (4) - - - (4) - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (407) 399 8 - - - - - - - -
Tax-related items - - - 581 581 - - - - - - - - - - - - - - - - - - - - -
Total - - - 575 575 - - - - - - - - - - (411) 399 8 - (4) - - - - - -
Non-U.S. Impairments - - (11) - (11) - - - - - - - - - - (116) - - (258) (374) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 847 847 - - - - - - - - - - - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (1,302) 1,290 12 - - - - - - - -
Tax-related items - - - - - - - - 49 49 - (9) - - (9) - - - (262) (262) - - - - - -
Total - - (11) - (11) - - - 896 896 - (9) - - (9) (1,418) 1,290 12 (520) (636) - - - - - -
Total Impairments - - (11) (6) (17) - - - - - - - - - - (120) - - (258) (378) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 847 847 - - - - - - - - - - - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (1,709) 1,689 20 - - - - - - - -
Tax-related items - - - 581 581 - - - 49 49 - (9) - - (9) - - - (262) (262) - - - - - -
Total - - (11) 575 564 - - - 896 896 - (9) - - (9) (1,829) 1,689 20 (520) (640) - - - - - -



Segmentation Basis (effective 2Q22)- Continued
Identified Items Earnings/(Loss), $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Chemical Products
United States Impairments - - - - - - - - - - - - - - - (90) - - - (90) - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - - (19) 19 - - - - - - - -
Tax-related items - - - 215 215 - - - - - - - - - - - - - - - - - - - - -
Total - - - 215 215 - - - - - - - - - - (90) (19) 19 - (90) - - - - - -
Non-U.S. Impairments - - - - - - - - - - - - - - - (2) - - - (2) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 1 1 - - - - - - - - - - - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (124) 60 64 - - - - - - - -
Tax-related items - - - - - - - - 155 155 - 2 - - 2 - - - (13) (13) - - - - - -
Total - - - - - - - - 156 156 - 2 - - 2 (126) 60 64 (13) (15) - - - - - -
Total Impairments - - - - - - - - - - - - - - - (92) - - - (92) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 1 1 - - - - - - - - - - - - - - - -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (124) 41 83 - - - - - - - -
Tax-related items - - - 215 215 - - - 155 155 - 2 - - 2 - - - (13) (13) - - - - - -
Total - - - 215 215 - - - 156 156 - 2 - - 2 (216) 41 83 (13) (105) - - - - - -
Specialty Products
United States Impairments - - - - - - - - - - - - - - - - - - - - - - - - - -
Gain/(loss) on sale of assets - - - - - - - - - - - - - - - - - - - - - - - 498 498 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - - (5) 5 - - - - - - - -
Tax-related items - - - 157 157 - - - - - - - - - - - - - - - - - - - - -
Total - - - 157 157 - - - - - - - - - - - (5) 5 - - - - - 498 498 -
Non-U.S. Impairments - - - - - - - - - - - - - - - (219) - - - (219) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 40 40 - - - - - - - - - - - - - 136 136 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - - (16) 16 - - - - - - - -
Tax-related items - - - - - - - - 65 65 - - - - - - - - (9) (9) - - - - - -
Total - - - - - - - - 105 105 - - - - - (219) (16) 16 (9) (228) - - - 136 136 -
Total Impairments - - - - - - - - - - - - - - - (219) - - - (219) - - - - - -
Gain/(loss) on sale of assets - - - - - - - - 40 40 - - - - - - - - - - - - - 634 634 -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - - (21) 21 - - - - - - - -
Tax-related items - - - 157 157 - - - 65 65 - - - - - - - - (9) (9) - - - - - -
Total - - - 157 157 - - - 105 105 - - - - - (219) (21) 21 (9) (228) - - - 634 634 -
Corporate and Financing Impairments - - - - - - - - - - - - - - - - - - (35) (35) - - - - - (98)
Gain/(loss) on sale of assets - - - - - - - - (6) (6) - - - (24) (24) - - - - - - - - (12) (12) -
Severance - - - - - - - - - - - - - - - - - - (326) (326) (31) (12) (5) (4) (52) -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax-related items - - - (2,133) (2,133) - - 348 - 348 - 25 307 - 332 - - - - - - - - - - -
Total - - - (2,133) (2,133) - - 348 (6) 342 - 25 307 (24) 308 - - - (361) (361) (31) (12) (5) (16) (64) (98)
Identified items impact attributable to ExxonMobil Impairments - (118) (109) (1,294) (1,521) - - - - - - - - - - (787) - - (19,273) (20,060) - - - (752) (752) (2,975)
Gain/(loss) on sale of assets - - - - - 366 - - 882 1,248 - - - 3,655 3,655 - - - - - - - - 1,081 1,081 -
Severance - - - - - - - - - - - - - - - - - - (326) (326) (31) (12) (5) (4) (52) -
Inventory valuation - lower of cost or market - - - - - - - - - - - - - - - (2,096) 1,922 113 - (61) - - - - - -
Tax-related items - - - 5,942 5,942 - - 619 269 888 - 505 307 268 1,080 - - - (581) (581) - - - - - -
Other - - - - - - - - (370) (370) - - - - - - - - - - - - - (250) (250) (378)
Total - (118) (109) 4,648 4,421 366 - 619 781 1,766 - 505 307 3,923 4,735 (2,883) 1,922 113 (20,180) (21,028) (31) (12) (5) 75 27 (3,353)


Attachment III - Earnings Excluding Identified Items Recast
Reclassified historical segment results are unaudited estimates.
Due to rounding, numbers presented may not add up precisely to the totals indicated.
As per previously reported data. Identified items as per frequently used terms from 2018 onwards. 2017 data shows reported Asset Impairments and U.S. Tax reform impacts.

Earnings/(loss) excluding identified items are earnings/(loss) excluding individually significant non-operational events with an absolute corporate total earnings impact of at least $250 million in a given quarter. The earnings/(loss) impact of an identified item for an individual segment may be less than $250 million when the item impacts several periods or several segments. Earnings/(loss) excluding identified items does include non-operational earnings events or impacts that are below the $250 million threshold utilized for identified items. When the effect of these events are material in aggregate, they are indicated in analysis of period results as part of quarterly earnings press release and teleconference materials. Management uses these figures to improve comparability of the underlying business across multiple periods by isolating and removing significant non-operational events from business results. The Corporation believes this view provides investors increased transparency into business results and trends, and provides investors with a view of the business as seen through the eyes of management. Earnings excluding identified items is not meant to be viewed in isolation or as a substitute for net income/(loss) attributable to ExxonMobil as prepared in accordance with U.S. GAAP.


Segmentation Basis (effective 2Q22)
Earnings/(Loss), $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Upstream United States (18) (183) (238) 7,061 6,622 429 439 606 265 1,739 96 335 37 68 536 (704) (1,197) (681) (16,803) (19,385) 363 663 869 1,768 3,663 2,376
Non-U.S. 2,270 1,367 1,805 1,291 6,733 3,068 2,601 3,623 3,048 12,340 2,780 2,926 2,131 6,069 13,906 1,240 (454) 298 (1,729) (645) 2,191 2,522 3,082 4,317 12,112 2,112
Total 2,252 1,184 1,567 8,352 13,355 3,497 3,040 4,229 3,313 14,079 2,876 3,261 2,168 6,137 14,442 536 (1,651) (383) (18,532) (20,030) 2,554 3,185 3,951 6,085 15,775 4,488
Energy Products United States 255 263 319 856 1,693 279 631 953 1,059 2,922 (195) 203 589 828 1,425 (183) (212) (300) (648) (1,342) (232) (278) 479 699 668 489
Non-U.S. 594 655 804 425 2,477 400 (172) 559 1,561 2,348 (175) 21 335 (164) 17 (645) 895 (399) (1,081) (1,230) (689) (578) 50 203 (1,014) (684)
Total 849 918 1,122 1,280 4,170 679 459 1,512 2,620 5,270 (369) 223 924 664 1,442 (828) 683 (699) (1,728) (2,572) (921) (856) 529 901 (347) (196)
Chemical Products United States 426 389 342 598 1,754 441 382 313 203 1,339 103 (23) 2 14 97 220 174 364 439 1,196 654 1,149 1,121 774 3,697 770
Non-U.S. 571 482 663 509 2,225 492 483 293 388 1,655 332 289 298 (240) 679 (4) 278 360 427 1,061 737 1,051 907 597 3,292 636
Total 997 870 1,005 1,107 3,979 933 865 606 591 2,994 435 266 301 (226) 776 215 451 724 866 2,257 1,391 2,200 2,027 1,371 6,989 1,405
Specialty Products United States 140 176 133 241 691 101 135 99 8 343 92 124 134 51 401 151 108 156 156 571 180 262 247 763 1,452 246
Non-U.S. 301 406 364 205 1,276 238 155 138 223 754 105 26 112 54 296 (5) 200 248 187 630 375 487 592 353 1,807 230
Total 441 582 497 446 1,966 339 290 237 231 1,097 196 150 246 105 697 146 309 405 342 1,201 555 750 839 1,116 3,259 476
Corporate and Financing (529) (204) (221) (2,806) (3,760) (798) (704) (344) (754) (2,600) (788) (770) (469) (990) (3,017) (679) (872) (727) (1,018) (3,296) (849) (588) (596) (603) (2,636) (694)
Net Income/(Loss) attributable
to ExxonMobil (U.S. GAAP)
4,010 3,350 3,970 8,380 19,710 4,650 3,950 6,240 6,000 20,840 2,350 3,130 3,170 5,690 14,340 (610) (1,080) (680) (20,070) (22,440) 2,730 4,690 6,750 8,870 23,040 5,480
Identified Items, $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Upstream United States - - (40) 7,121 7,081 - - - (274) (274) - - - - - (360) 45 - (16,777) (17,092) - - - (263) (263) -
Non-U.S. - (118) (58) (1,287) (1,463) 366 - 271 (96) 541 - 487 - 3,947 4,434 (259) 168 (11) (2,500) (2,602) - - - (280) (280) (3,255)
Total - (118) (98) 5,834 5,618 366 - 271 (370) 267 - 487 - 3,947 4,434 (619) 213 (11) (19,277) (19,694) - - - (543) (543) (3,255)
Energy Products United States - - - 575 575 - - - - - - - - - - (411) 399 8 - (4) - - - - - -
Non-U.S. - - (11) - (11) - - - 896 896 - (9) - - (9) (1,418) 1,290 12 (520) (636) - - - - - -
Total - - (11) 575 564 - - - 896 896 - (9) - - (9) (1,829) 1,689 20 (520) (640) - - - - - -
Chemical Products United States - - - 215 215 - - - - - - - - - - (90) (19) 19 - (90) - - - - - -
Non-U.S. - - - - - - - - 156 156 - 2 - - 2 (126) 60 64 (13) (15) - - - - - -
Total - - - 215 215 - - - 156 156 - 2 - - 2 (216) 41 83 (13) (105) - - - - - -
Specialty Products United States - - - 157 157 - - - - - - - - - - - (5) 5 - - - - - 498 498 -
Non-U.S. - - - - - - - - 105 105 - - - - - (219) (16) 16 (9) (228) - - - 136 136 -
Total - - - 157 157 - - - 105 105 - - - - - (219) (21) 21 (9) (228) - - - 634 634 -
Corporate and Financing - - - (2,133) (2,133) - - 348 (6) 342 - 25 307 (24) 308 - - - (361) (361) (31) (12) (5) (16) (64) (98)
Total Identified Items - (118) (109) 4,648 4,421 366 - 619 781 1,766 - 505 307 3,923 4,735 (2,883) 1,922 113 (20,180) (21,028) (31) (12) (5) 75 27 (3,353)
Earnings/(Loss) excluding identified items, $M 1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Upstream United States (18) (183) (198) (60) (459) 429 439 606 539 2,013 96 335 37 68 536 (344) (1,242) (681) (26) (2,293) 363 663 869 2,031 3,926 2,376
Non-U.S. 2,270 1,485 1,863 2,578 8,196 2,702 2,601 3,352 3,144 11,799 2,780 2,439 2,131 2,122 9,472 1,499 (622) 309 771 1,957 2,191 2,522 3,082 4,597 12,392 5,367
Total 2,252 1,302 1,665 2,518 7,737 3,131 3,040 3,958 3,683 13,812 2,876 2,774 2,168 2,190 10,008 1,155 (1,864) (372) 745 (336) 2,554 3,185 3,951 6,628 16,318 7,743
Energy Products United States 255 263 319 281 1,118 279 631 953 1,059 2,922 (195) 203 589 828 1,425 228 (611) (308) (648) (1,338) (232) (278) 479 699 668 489
Non-U.S. 594 655 815 425 2,488 400 (172) 559 665 1,452 (175) 30 335 (164) 26 773 (395) (411) (561) (594) (689) (578) 50 203 (1,014) (684)
Total 849 918 1,133 705 3,606 679 459 1,512 1,724 4,374 (369) 232 924 664 1,451 1,001 (1,006) (719) (1,208) (1,932) (921) (856) 529 901 (347) (196)
Chemical Products United States 426 389 342 383 1,539 441 382 313 203 1,339 103 (23) 2 14 97 310 193 345 439 1,286 654 1,149 1,121 774 3,697 770
Non-U.S. 571 482 663 509 2,225 492 483 293 232 1,499 332 287 298 (240) 677 122 218 296 440 1,076 737 1,051 907 597 3,292 636
Total 997 870 1,005 892 3,764 933 865 606 435 2,838 435 264 301 (226) 774 431 410 641 879 2,362 1,391 2,200 2,027 1,371 6,989 1,405
Specialty Products United States 140 176 133 84 534 101 135 99 8 343 92 124 134 51 401 151 113 151 156 571 180 262 247 265 954 246
Non-U.S. 301 406 364 205 1,276 238 155 138 118 649 105 26 112 54 296 214 216 232 196 858 375 487 592 217 1,672 230
Total 441 582 497 289 1,809 339 290 237 126 992 196 150 246 105 697 365 330 384 351 1,429 555 750 839 482 2,625 476
Corporate and Financing (529) (204) (221) (673) (1,627) (798) (704) (692) (748) (2,942) (788) (795) (776) (966) (3,325) (679) (872) (727) (657) (2,935) (818) (576) (591) (587) (2,572) (596)
Earnings/(Loss) excluding identified items (non GAAP) 4,010 3,468 4,079 3,732 15,289 4,284 3,950 5,621 5,219 19,074 2,350 2,625 2,863 1,767 9,605 2,273 (3,002) (793) 110 (1,412) 2,761 4,702 6,755 8,795 23,013 8,833


Attachment IV - Capex Recast
Reclassified historical segment results are unaudited estimates.
Due to rounding, numbers presented may not add up precisely to the totals indicated.



Segmentation Basis (Prior to 2Q22)
Capital and Exploration Expenditures, $M 2017 2018 2019 2020 2021 1Q22
Upstream
United States 3,716 7,670 11,653 6,817 4,018 1,369
Non-U.S. 12,979 12,524 11,832 7,614 8,236 2,510
Total 16,695 20,194 23,485 14,431 12,254 3,879
Downstream
United States 823 1,186 2,353 2,344 1,000 394
Non-U.S. 1,701 2,243 2,018 1,877 1,095 183
Total 2,524 3,429 4,371 4,221 2,095 577
Chemical
United States 1,583 1,747 2,547 2,002 1,367 234
Non-U.S. 2,188 488 718 714 876 214
Total 3,771 2,235 3,265 2,716 2,243 448
Other 90 65 27 6 3 -
Total Capital and Exploration Expenditures 23,080 25,923 31,148 21,374 16,595 4,904
Segmentation Basis (effective 2Q22)
Capital and Exploration Expenditures, $M 2017 2018 2019 2020 2021 1Q22
Upstream
United States 3,716 7,670 11,653 6,817 4,018 1,369
Non-U.S. 12,979 12,524 11,832 7,614 8,236 2,510
Total 16,695 20,194 23,485 14,431 12,254 3,879
Energy Products
United States 802 1,158 2,282 2,296 982 392
Non-U.S. 3,336 1,883 1,782 1,592 1,005 174
Total 4,138 3,041 4,064 3,888 1,987 566
Chemical Products
United States 1,562 1,705 2,514 1,939 1,200 231
Non-U.S. 235 300 590 655 825 205
Total 1,797 2,005 3,104 2,594 2,025 436
Specialty Products
United States 42 70 104 111 185 5
Non-U.S. 318 548 364 344 141 18
Total 360 618 468 455 326 23
Other 90 65 27 6 3 -
Total Capital and Exploration Expenditures 23,080 25,923 31,148 21,374 16,595 4,904


Attachment V - Product Sales Recast
Reclassified historical segment results are unaudited estimates.
Due to rounding, numbers presented may not add up precisely to the totals indicated.
Recast for Petroleum product sales and Chemical prime product sales only; Upstream volumes and Refinery throughput not impacted by the segmentation recast.



Segmentation Basis (prior to 2Q22)
1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Petroleum Product Sales, kbd
United States 2,155 2,187 2,209 2,209 2,190 2,128 2,215 2,267 2,230 2,210 2,210 2,264 2,336 2,356 2,292 2,231 1,959 2,297 2,128 2,154 2,077 2,218 2,346 2,383 2,257 2,256
Canada 494 494 508 501 499 484 514 527 516 510 484 482 492 444 476 456 353 446 415 418 409 421 472 488 448 442
Europe 1,536 1,653 1,608 1,589 1,597 1,574 1,595 1,582 1,474 1,556 1,510 1,443 1,508 1,456 1,479 1,403 1,130 1,253 1,227 1,253 1,272 1,297 1,404 1,384 1,340 1,345
Asia Pacific 708 755 746 819 757 795 814 824 825 815 749 775 700 729 738 708 640 614 645 651 665 655 648 643 653 644
Other 502 469 471 506 487 451 364 416 450 421 462 444 468 497 467 489 355 413 418 419 458 450 457 493 464 471
Worldwide 5,395 5,558 5,542 5,624 5,530 5,432 5,502 5,616 5,495 5,512 5,415 5,408 5,504 5,482 5,452 5,287 4,437 5,023 4,833 4,895 4,881 5,041 5,327 5,391 5,162 5,158
Gasolines, naphthas 2,163 2,265 2,266 2,353 2,262 2,215 2,216 2,255 2,183 2,217 2,149 2,198 2,255 2,276 2,220 2,122 1,736 2,077 2,039 1,994 1,996 2,117 2,191 2,325 2,158 2,114
Heating oils, kerosene, diesel 1,833 1,850 1,836 1,878 1,850 1,828 1,781 1,837 1,915 1,840 1,914 1,820 1,833 1,903 1,867 1,867 1,649 1,750 1,739 1,751 1,692 1,704 1,796 1,804 1,749 1,722
Aviation fuels 370 383 380 393 382 396 405 430 376 402 386 391 445 399 406 383 147 152 172 213 183 201 228 267 220 289
Heavy fuels 380 367 372 370 371 346 432 411 387 395 299 308 261 217 270 256 262 242 237 249 257 275 276 265 269 249
Specialty products 649 693 688 630 665 647 668 683 634 658 667 691 710 687 689 659 643 802 646 688 753 744 836 730 766 784
Worldwide 5,395 5,558 5,542 5,624 5,530 5,432 5,502 5,616 5,495 5,512 5,415 5,408 5,504 5,482 5,452 5,287 4,437 5,023 4,833 4,895 4,881 5,041 5,327 5,391 5,162 5,158
Chemical Prime Product Sales, kt
United States 2,280 2,334 2,294 2,399 9,307 2,391 2,411 2,445 2,577 9,824 2,322 2,295 2,216 2,294 9,127 2,195 1,985 2,363 2,467 9,010 2,190 2,491 2,531 2,512 9,724 2,704
Non-U.S. 3,792 3,786 4,152 4,383 16,113 4,277 4,441 4,232 4,095 17,045 4,450 4,404 4,260 4,275 17,389 4,042 3,960 4,261 4,176 16,439 4,256 4,022 4,141 4,189 16,608 4,033
Worldwide 6,072 6,120 6,446 6,782 25,420 6,668 6,852 6,677 6,672 26,869 6,772 6,699 6,476 6,569 26,516 6,237 5,945 6,624 6,643 25,449 6,446 6,513 6,672 6,701 26,332 6,737
Segmentation Basis (effective 2Q22)
1Q17 2Q17 3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21 4Q21 2021 1Q22
Energy Products, kbd
Gasolines, naphthas 2,163 2,265 2,266 2,353 2,262 2,215 2,216 2,255 2,183 2,217 2,149 2,198 2,255 2,276 2,220 2,122 1,736 2,077 2,039 1,994 1,996 2,117 2,191 2,325 2,158 2,114
Heating oils, kerosene, diesel 1,833 1,850 1,836 1,878 1,850 1,828 1,781 1,837 1,915 1,840 1,914 1,820 1,833 1,903 1,867 1,867 1,649 1,750 1,739 1,751 1,692 1,704 1,796 1,804 1,749 1,722
Aviation fuels 370 383 380 393 382 396 405 430 376 402 386 391 445 399 406 383 147 152 172 213 183 201 228 267 220 289
Heavy fuels 380 367 372 370 371 346 432 411 387 395 299 308 261 217 270 256 262 242 237 249 257 275 276 265 269 249
Other energy products 605 665 667 638 645 650 670 683 612 653 664 680 692 667 677 623 634 749 614 656 705 709 811 712 734 737
Worldwide 5,351 5,530 5,521 5,632 5,510 5,435 5,504 5,616 5,473 5,507 5,412 5,397 5,486 5,462 5,440 5,251 4,428 4,970 4,801 4,863 4,832 5,006 5,302 5,373 5,130 5,111
Energy Products, kbd
United States 2,156 2,195 2,205 2,219 2,194 2,132 2,219 2,275 2,244 2,218 2,222 2,268 2,340 2,361 2,298 2,232 1,966 2,293 2,143 2,159 2,077 2,230 2,361 2,396 2,267 2,262
Non-U.S. 3,195 3,335 3,316 3,413 3,315 3,303 3,285 3,340 3,229 3,289 3,191 3,129 3,146 3,102 3,141 3,019 2,462 2,677 2,658 2,704 2,756 2,776 2,941 2,976 2,863 2,849
Worldwide 5,351 5,530 5,521 5,632 5,510 5,435 5,504 5,616 5,473 5,507 5,412 5,397 5,486 5,462 5,440 5,251 4,428 4,970 4,801 4,863 4,833 5,006 5,302 5,373 5,130 5,111
Chemical Products, kt
United States 1,624 1,614 1,764 1,698 6,700 1,729 1,736 1,790 1,871 7,126 1,626 1,659 1,604 1,685 6,574 1,612 1,457 1,787 1,747 6,602 1,622 1,782 1,807 1,807 7,017 2,032
Non-U.S. 2,658 2,608 2,832 2,832 10,930 2,758 2,871 2,800 2,888 11,317 3,128 3,056 3,042 3,045 12,270 2,917 2,914 3,212 3,143 12,186 3,144 2,949 3,007 3,026 12,126 2,986
Worldwide 4,282 4,222 4,595 4,530 17,630 4,487 4,607 4,591 4,759 18,444 4,753 4,715 4,646 4,730 18,844 4,528 4,371 4,999 4,889 18,787 4,765 4,731 4,814 4,833 19,142 5,018
Specialty Products, kt
United States 570 544 513 503 2,131 535 544 483 466 2,028 486 507 489 481 1,963 503 388 540 466 1,897 509 495 471 467 1,943 522
Non-U.S. 1,463 1,421 1,339 1,383 5,606 1,341 1,391 1,341 1,450 5,523 1,303 1,349 1,308 1,342 5,303 1,385 1,082 1,457 1,416 5,340 1,485 1,447 1,424 1,368 5,723 1,484
Worldwide 2,033 1,965 1,852 1,886 7,736 1,876 1,935 1,824 1,916 7,551 1,790 1,856 1,797 1,823 7,266 1,889 1,470 1,997 1,882 7,237 1,995 1,942 1,896 1,835 7,666 2,006

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Exxon Mobil Corporation published this content on 17 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 June 2022 20:53:01 UTC.